Z79.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z79.2 became effective on October 1, 2021. This is the American ICD-10-CM version of Z79.2 - other international versions of ICD-10 Z79.2 may differ. Z codes represent reasons for encounters.
Long term (current) use of antibiotics. Z79.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM Z79.2 became effective on October 1, 2019.
Z79.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM Z79.2 became effective on October 1, 2020. This is the American ICD-10-CM version of Z79.2 - other international versions of ICD-10 Z79.2 may differ. Z codes represent reasons for encounters.
ICD-10 code H61.20 for Impacted cerumen, unspecified ear is a medical classification as listed by WHO under the range - Diseases of the ear and mastoid process. Subscribe to Codify and get the code details in a flash. Request a Demo 14 Day Free Trial Buy Now
ICD-10 code Z79. 899 for Other long term (current) drug therapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Persons encountering health services in other specified circumstancesZ76. 89 is a valid ICD-10-CM diagnosis code meaning 'Persons encountering health services in other specified circumstances'. It is also suitable for: Persons encountering health services NOS.
Long term (current) use of antibiotics Z79. 2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z79. 2 became effective on October 1, 2021.
Long term (current) drug use - V58. 6 codes are for use for when the patient has been on a medication for an extended time, or when the medication has been currently prescribed with the intent of long term use.
Persons encountering health services in other specified circumstancesICD-10 code Z76. 89 for Persons encountering health services in other specified circumstances is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
ICD-10-PCS GZ3ZZZZ is a specific/billable code that can be used to indicate a procedure.
Z45. 1 - Encounter for adjustment and management of infusion pump | ICD-10-CM.
9: Fever, unspecified.
96365: “Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to one hour”
The ICD-10 section that covers long-term drug therapy is Z79, with many subsections and specific diagnosis codes.
A: Assign a code from Z79 if the patient is receiving a medication for an extended period as a prophylactic measure (such as for the prevention of deep vein thrombosis) or as treatment of a chronic condition (such as arthritis) or a disease requiring a lengthy course of treatment (such as cancer).
ICD-10 code Z51. 81 for Encounter for therapeutic drug level monitoring is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
DRG Group #154-156 - Other ear, nose, mouth and throat diagnoses with MCC.
The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code H61.20. Click on any term below to browse the alphabetical index.
This is the official approximate match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that while there is no exact mapping between this ICD10 code H61.20 and a single ICD9 code, 380.4 is an approximate match for comparison and conversion purposes.
These coding guidelines specifically address the documentation of medical necessity on the claim, i.e., the coding in this guidance must be used to indicate the conditions that convey medical necessity of the drug treatment.
The National Coverage Determination (NCD) on Erythropoiesis Stimulating Agents (ESAs) describes the conditions for which ESAs may be covered for “chemotherapyinduced anemia”. Whenever payment is sought for ESA treatment chemotherapyinduced anemia, the medical record must document the physician’s rationale for the determining that the anemia is “chemotherapy-induced”.